Showing results (51-60 of 344) with videos related to

Sort By:
Pageof 35
Journal of Hypertension|December 1, 1995
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary reportG Y Lip, A D Blann, J Zarifis, et al.
Acta Ophthalmologica Scandinavica|November 24, 1998
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?P L Lip, A F Jones, N Price, et al.
International Journal of Cardiology|October 31, 2000
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapyF L Li-Saw-Hee, E Edmunds, A D Blann, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 19, 2001
Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke ProjectG Y Lip, A D Blann, I S Farooqi, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 1, 1997
A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation ProjectG Y Lip, D J Golding, M Nazir, et al.
The American Journal of Cardiology|March 16, 2001
Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertensionF M Belgore, A D Blann, F L Li-Saw-Hee, et al.
American Journal of Hypertension|July 24, 2001
A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damageG Y Lip, E Edmunds, S C Martin, et al.
QJM : Monthly Journal of the Association of Physicians|October 1, 1996
Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapyI Rajman, G Y Lip, R Cramb, et al.
Circulation|August 1, 1996
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirinG Y Lip, P L Lip, J Zarifis, et al.
QJM : Monthly Journal of the Association of Physicians|June 8, 2001
Dyslipidaemia in patients with malignant-phase hypertensionE Edmunds, M J Landray, F L Li-Saw-Hee, et al.
Pageof 35